{"entity":{"type":"insider","cik":"0001502213","url":"/insider/0001502213","json_url":"/insider/0001502213.json","name":"Chai-Onn Robert Roswell","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2010-11-12","last":"2015-05-06","span_basis":"filed_date"},"name_variants":[{"name":"Chai-Onn Robert Roswell","source":"filing","n_filings":8,"first_seen":"2010-11-12","last_seen":"2015-05-06"}],"transactions":[{"id":8894404,"accession":"0000885590-15-000034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-15-000034","line_url":"/filing/0000885590-15-000034#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001502213","owner_name":"Chai-Onn Robert Roswell","owner_display_name":"Chai-Onn Robert Roswell","owner_url":"/insider/0001502213","role":"Officer (EVP, CLO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CLO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CLO, General Counsel","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90938.0,"shares_display":"90,938","price_per_share":222.5411,"price_display":"222.54","price_state":"stated","total_value":20237442.5518,"total_display":"20,237,442.55","total_whole":"20,237,443","shares_owned_after":43187.0,"shares_owned_after_display":"43,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-04","filed_date":"2015-05-06","scope":"insider"},{"id":8196311,"accession":"0000885590-15-000019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-15-000019","line_url":"/filing/0000885590-15-000019#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001502213","owner_name":"Chai-Onn Robert Roswell","owner_display_name":"Chai-Onn Robert Roswell","owner_url":"/insider/0001502213","role":"Officer (EVP, CLO, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, CLO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CLO, General Counsel","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90939.0,"shares_display":"90,939","price_per_share":200.0142,"price_display":"200.01","price_state":"stated","total_value":18189091.3338,"total_display":"18,189,091.33","total_whole":"18,189,091","shares_owned_after":21379.0,"shares_owned_after_display":"21,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-04","scope":"insider"},{"id":6853807,"accession":"0000885590-14-000054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-14-000054","line_url":"/filing/0000885590-14-000054#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001502213","owner_name":"Chai-Onn Robert Roswell","owner_display_name":"Chai-Onn Robert Roswell","owner_url":"/insider/0001502213","role":"Officer (EVP, Gen. Couns. & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Couns. & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Couns. & Corp. Secy.","security_title":"Common Stock, no par values","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10203.0,"shares_display":"10,203","price_per_share":121.6971,"price_display":"121.70","price_state":"stated","total_value":1241675.5113,"total_display":"1,241,675.51","total_whole":"1,241,676","shares_owned_after":23999.0,"shares_owned_after_display":"23,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-23","filed_date":"2014-06-24","scope":"insider"},{"id":6424240,"accession":"0000885590-14-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-14-000040","line_url":"/filing/0000885590-14-000040#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001502213","owner_name":"Chai-Onn Robert Roswell","owner_display_name":"Chai-Onn Robert Roswell","owner_url":"/insider/0001502213","role":"Officer (EVP, Gen. Couns. & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Couns. & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Couns. & Corp. Secy.","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":130.0836,"price_display":"130.08","price_state":"stated","total_value":1300836.0,"total_display":"1,300,836.00","total_whole":"1,300,836","shares_owned_after":23999.0,"shares_owned_after_display":"23,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-13","filed_date":"2014-05-14","scope":"insider"},{"id":6301473,"accession":"0000885590-14-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-14-000029","line_url":"/filing/0000885590-14-000029#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001502213","owner_name":"Chai-Onn Robert Roswell","owner_display_name":"Chai-Onn Robert Roswell","owner_url":"/insider/0001502213","role":"Officer (EVP, Gen. Couns. & Corp. Secy)","role_mark":"O","role_mark_label":"Officer (EVP, Gen. Couns. & Corp. Secy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Gen. Couns. & Corp. Secy.","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":141.72,"price_display":"141.72","price_state":"stated","total_value":708600.0,"total_display":"708,600.00","total_whole":"708,600","shares_owned_after":23999.0,"shares_owned_after_display":"23,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-17","filed_date":"2014-03-19","scope":"insider"},{"id":5194058,"accession":"0000885590-13-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-13-000076","line_url":"/filing/0000885590-13-000076#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001502213","owner_name":"Chai-Onn Robert Roswell","owner_display_name":"Chai-Onn Robert Roswell","owner_url":"/insider/0001502213","role":"Officer (EVP, GC and Corp. Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, GC and Corp. Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GC and Corp. Secretary","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5032.0,"shares_display":"5,032","price_per_share":99.299,"price_display":"99.30","price_state":"stated","total_value":499672.568,"total_display":"499,672.57","total_whole":"499,673","shares_owned_after":188277.0,"shares_owned_after_display":"188,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-23","filed_date":"2013-08-23","scope":"insider"},{"id":9020126,"accession":"0000885590-11-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000885590-11-000035","line_url":"/filing/0000885590-11-000035#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001502213","owner_name":"Chai-Onn Robert Roswell","owner_display_name":"Chai-Onn Robert Roswell","owner_url":"/insider/0001502213","role":"Officer (EVP, GC & Corp. Sec)","role_mark":"O","role_mark_label":"Officer (EVP, GC & Corp. Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GC & Corp. Sec.","security_title":"Common Stock, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":50.76,"price_display":"50.76","price_state":"stated","total_value":507600.0,"total_display":"507,600.00","total_whole":"507,600","shares_owned_after":167774.0,"shares_owned_after_display":"167,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-27","filed_date":"2011-06-01","scope":"insider"},{"id":7618823,"accession":"0001502213-10-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001502213-10-000002","line_url":"/filing/0001502213-10-000002#line-1","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001502213","owner_name":"Chai-Onn Robert Roswell","owner_display_name":"Chai-Onn Robert Roswell","owner_url":"/insider/0001502213","role":"Officer (EVP, GC & Corp. Sec)","role_mark":"O","role_mark_label":"Officer (EVP, GC & Corp. Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GC & Corp. Sec.","security_title":"Common Shares, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35607.0,"shares_display":"35,607","price_per_share":25.95,"price_display":"25.95","price_state":"stated","total_value":924001.65,"total_display":"924,001.65","total_whole":"924,002","shares_owned_after":18511.0,"shares_owned_after_display":"18,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-09","filed_date":"2010-11-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000885590","name":"Valeant Pharmaceuticals International, Inc.","url":"/issuer/0000885590","role":"Officer (EVP, CLO, General Counsel)","n_filings":8,"first_seen":"2010-11-12","last_seen":"2015-05-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001502213","retrieved_at":"2026-08-26T09:34:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}